Cecily Forsyth

3.6k total citations
57 papers, 908 citations indexed

About

Cecily Forsyth is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Cecily Forsyth has authored 57 papers receiving a total of 908 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Hematology, 30 papers in Genetics and 11 papers in Pathology and Forensic Medicine. Recurrent topics in Cecily Forsyth's work include Chronic Lymphocytic Leukemia Research (14 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (11 papers) and Lymphoma Diagnosis and Treatment (11 papers). Cecily Forsyth is often cited by papers focused on Chronic Lymphocytic Leukemia Research (14 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (11 papers) and Lymphoma Diagnosis and Treatment (11 papers). Cecily Forsyth collaborates with scholars based in Australia, United States and New Zealand. Cecily Forsyth's co-authors include David S Celermajer, Wendy Jessup, J. Robinson, Mark Adams, Claire Harrison, Peter J. Campbell, Georgina Buck, Keith Wheatley, Anthony R. Green and Jean‐Jacques Kiladjian and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of the American College of Cardiology.

In The Last Decade

Cecily Forsyth

54 papers receiving 870 citations

Peers

Countries citing papers authored by Cecily Forsyth

Since Specialization

Citations

This map shows the geographic impact of Cecily Forsyth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cecily Forsyth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cecily Forsyth more than expected).

Fields of papers citing papers by Cecily Forsyth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cecily Forsyth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cecily Forsyth. The network helps show where Cecily Forsyth may publish in the future.

Co-authorship network of co-authors of Cecily Forsyth

This figure shows the co-authorship network connecting the top 25 collaborators of Cecily Forsyth. A scholar is included among the top collaborators of Cecily Forsyth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cecily Forsyth. Cecily Forsyth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Variability of bone marrow biopsy reporting affects accuracy of diagnosis of myeloproliferative neoplasms: data from the ALLG MPN01 registry 2023 ·Pathology ·(unknown), Wendy N. Erber, Andrew Grigg, (unknown), Andrew C. Perkins, Cecily Forsyth, David M. Ross	4
2	2684 Two forms of neuropathy associated with imatinib therapy: a case report 2023 ·(unknown), (unknown), Cecily Forsyth, (unknown)	0
3	Long‐term effectiveness of eculizumab: Data from the International PNH Registry 2023 ·European Journal Of Haematology ·Louis Terriou, Jong Wook Lee, Cecily Forsyth, Morag Griffin, Jeff Szer, Alexander Röth, (unknown), Jesse Metzger, Ami Patel, Christopher J. Patriquin	9
4	Paraprotein associated heparin resistance during cardiopulmonary bypass 2022 ·Perfusion ·(unknown), Cecily Forsyth, (unknown), (unknown), (unknown), (unknown)	2
5	Non-anaemic iron deficiency 2021 ·Australian Prescriber ·(unknown), Cecily Forsyth	30
6	Two monogenic disorders masquerading as one: severe congenital neutropenia with monocytosis and non-syndromic sensorineural hearing loss 2020 ·BMC Medical Genetics ·Parvathy Venugopal, Lucia Gagliardi, Cecily Forsyth, Jinghua Feng, Kerry Phillips, Milena Babic, Nicola Poplawski, Hugh Young Rienhoff, Andreas Schreiber, Christopher N Hahn, Anna Brown, Hamish S. Scott	2
7	Correction to: Efficacy and Safety of ABP 798: Results from the JASMINE Trial in Patients with Follicular Lymphoma in Comparison with Rituximab Reference Product 2020 ·Targeted Oncology ·Dietger Niederwieser, Caroline Hamm, Patrick Cobb, (unknown), Cecily Forsyth, Alessandra Tucci, Vladimir Hanes, Vincent Delwail, Roman Hájek, David Chien	1
8	Hydroxycarbamide Plus Aspirin Versus Aspirin Alone in Patients With Essential Thrombocythemia Age 40 to 59 Years Without High-Risk Features 2018 ·Journal of Clinical Oncology ·Anna L. Godfrey, Peter J. Campbell, Cathy MacLean, Georgina Buck, (unknown), (unknown), Bridget S. Wilkins, Keith Wheatley, Jyoti Nangalia, Jacob Grinfeld, Mary Frances McMullin, Cecily Forsyth, Jean‐Jacques Kiladjian, Anthony R. Green, Claire Harrison, (unknown), (unknown)	49
9	Hydroxycarbamide Plus Aspirin Vs Aspirin Alone in Intermediate Risk Essential Thrombocythemia: Results of the PT-1 International, Prospective, Randomized Clinical Trial 2017 ·Blood ·Anna L. Godfrey, Peter J. Campbell, Cathy MacLean, Georgina Buck, Clare East, (unknown), (unknown), Bridget S. Wilkins, Keith Wheatley, Jyoti Nangalia, Jacob Grinfeld, Mary Frances McMullin, Cecily Forsyth, Jean‐Jacques Kiladjian, Anthony R. Green, Claire Harrison	0
10	Clinicopathological differences exist between CALR- and JAK2-mutated myeloproliferative neoplasms despite a similar molecular landscape: data from targeted next-generation sequencing in the diagnostic laboratory 2017 ·Annals of Hematology ·Rishu Agarwal, Piers Blombery, Michelle McBean, Kate Jones, Andrew Fellowes, Ken Doig, Cecily Forsyth, David Westerman	14
11	Busulfan is effective second-line therapy for older patients with Philadelphia-negative myeloproliferative neoplasms intolerant of or unresponsive to hydroxyurea 2016 ·Leukemia & lymphoma ·(unknown), Claire Harrison, Cecily Forsyth, Michael Bennett, William Stevenson, (unknown), (unknown), David Ritchie, David M. Ross, Andrew Grigg	10
12	Perioperative and peripartum prevention of venous thromboembolism in patients with hereditary antithrombin deficiency using recombinant antithrombin therapy 2014 ·Blood Coagulation & Fibrinolysis ·Michael J. Paidas, Cecily Forsyth, I. Quéré, Marc Rodger, Johan Frieling, Robert C. Tait	14
13	When should iron chelation therapy be considered in patients with myelodysplasia and other bone marrow failure syndromes with iron overload? 2012 ·Internal Medicine Journal ·Robert Bird, Melita Kenealy, Cecily Forsyth, (unknown), Michael F. Leahy, John F. Seymour, Luen Bik To	9
14	Immunoglobulin G subclass deficiency and infection risk in 150 patients with chronic lymphocytic leukemia 2012 ·Leukemia & lymphoma ·(unknown), (unknown), Giles Best, Cecily Forsyth, (unknown), Ping Han, William Stevenson, Stephen P. Mulligan	75
15	The Hsp90 inhibitor SNX-7081 synergizes with and restores sensitivity to fludarabine in chronic lymphocytic leukemia cells with lesions in the TP53 pathway: a potential treatment strategy for fludarabine refractory disease 2011 ·Leukemia & lymphoma ·Giles Best, (unknown), Nisha Singh, Cecily Forsyth, Richard I. Christopherson, Stephen P. Mulligan	12
16	The novel Hsp‐90 inhibitor SNX7081 is significantly more potent than 17‐AAG against primary CLL cells and a range of haematological cell lines, irrespective of lesions in the TP53 pathway 2010 ·British Journal of Haematology ·Giles Best, Nisha Singh, Cecily Forsyth, Stephen P. Mulligan	13
17	Abnormal dicentric chromosome with co-amplification of sequences from chromosomes 11 and 19 2001 ·Cancer Genetics and Cytogenetics ·Arabella Smith, Luke St Heaps, Praveen Sharma, (unknown), Cecily Forsyth	4
18	Oral l-arginine inhibits platelet aggregation but does not enhance endothelium-dependent dilation in healthy young men 1995 ·Journal of the American College of Cardiology ·Mark Adams, Cecily Forsyth, Wendy Jessup, J. Robinson, David S Celermajer	144
19	Rapid detection of Rh(D)‐ or K‐positive fetal red cells in chorion villus samples by a flow cytometric technique 1994 ·Transfusion Medicine ·Margaret Nelson, Cecily Forsyth, Henning D. Popp, John Gibson	6
20	The Management of .22 Caliber Gunshot Wounds of the Brain: A Review of 49 Cases 1987 ·Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques ·(unknown), Brian W. Weir, Cecily Forsyth	48

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact